Dr. Raymond Mailhot Vega, Intern, Washington University in St. Louis School of Medicine
Stations, the following is a news announcement. Suggested lead in 3, 2, 1…
More than 11,000 of the world’s top cancer doctors and scientists gathered at the 55th annual meeting of the American Society for Radiation Oncology (ASTRO) in Atlanta. This year’s theme of the four-day event, starting Monday, September 22, is “Patients: Hope, Guide, Heal,” focused on quality, safety and patient-centered care.
Dr. Raymond Mailhot Vega, intern at Washington University in St. Louis School of Medicine, outlines the benefits of proton therapy.
THE OBJECTIVE OF OUR STUDY WAS TO COMPARE TWO DIFFERENT TYPES OF RADIATION TREATMENT IN A PARTICULAR BRAIN CANCER OF CHILDREN. THOSE TWO TYPES WERE PROTON THERAPY AND PHOTON THERAPY. PROTON THERAPY HAS BEEN IN THE MEDIA A LOT BECAUSE IT HAS A POTENTIAL TO SPARE HEALTHY TISSUE FROM GETTING RADIATION, AND THAT POTENTIAL MAY DECREASE SIDE EFFECTS FROM RADIATION LIKE HEARING LOSS, HEART TROUBLE AND SECONDARY CANCERS LATER IN LIFE. SO WE COMPARED THE TWO TYPES USING THE BEST DATA AVAILABLE WITH MODELING STUDIES AND PATIENT OUTCOMES DATA TO DETERMINE THAT PROTON THERAPY WAS COST EFFECTIVE FOR THIS TYPE OF CANCER.
For more information, visit www.astro.org.